Blood Platelets Market Report 2026

Blood Platelets Market Overview

• Blood Platelets market size has reached to $6.7 billion in 2025 • Expected to grow to $9.28 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Increasing Prevalence Of Blood Disorders Fueling The Growth Of The Market Due To Rising Aging Population And Bone Marrow Decline • Market Trend: Innovative Platelet Pooling Extends Shelf Life And Enhances Availability • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Blood Platelets Market?

Blood platelets, also known as thrombocytes are small, disc-shaped cell fragments in the blood that help in clot formation and wound healing. They prevent excessive bleeding adhering to damaged blood vessel walls, aggregating with other platelets, and releasing clotting factors to stabilize the clot and prevent excessive blood loss. They are produced in the bone marrow and are essential for hemostasis and blood vessel repair. The main platelet types in the blood platelets market are whole blood derived platelets and apheresis derived platelets. Whole blood-derived platelets are obtained by separating platelets from a standard whole blood donation, often pooled from multiple donors for transfusion. The applications include platelet function disorders, hemophilia, thrombocytopenia, and perioperative indications, while the end-users encompass hospitals, ambulatory surgical centers, blood banks, research laboratories, specialty clinics, cancer treatment center, trauma center and others.

What Is The Blood Platelets Market Growth Forecast?

The blood platelets market size is expected to see strong growth in the next few years. It will grow to $9.28 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing prevalence of thrombocytopenia cases, rising demand from cancer treatment centers, expansion of advanced transfusion services, growing focus on transfusion safety, investments in next-generation platelet storage technologies. Major trends in the forecast period include increasing use of apheresis-derived platelets, rising adoption of pathogen-reduced platelet products, expansion of automated platelet collection systems, growing focus on platelet shelf-life extension, enhanced monitoring of platelet quality.

Global Blood Platelets Market Segmentation

1) By Platelet Type: Whole Blood Derived Platelets, Apheresis Derived Platelets 2) By Application: Platelet Function Disorder, Hemophilia, Thrombocytopenia, Perioperative Indication 3) By End-Users: Hospitals, Ambulatory Surgical Centers, Blood Banks, Research Laboratories, Specialty Clinics, Cancer Treatment Center, Trauma Center, Other End Users Subsegments: 1) By Whole Blood Derived Platelets: Leukocyte-Reduced Whole Blood Platelets, Non-Leukocyte-Reduced Whole Blood Platelets, Pathogen-Reduced Whole Blood Platelets 2) By Apheresis Derived Platelets: Single-Donor Apheresis Platelets, Leukocyte-Reduced Apheresis Platelets, Pathogen-Reduced Apheresis Platelets

What Is The Driver Of The Blood Platelets Market?

The increasing prevalence of blood disorders is expected to propel the growth of the blood platelets market going forward. Blood disorders refer to conditions that affect the function, production, or components of blood, including red blood cells, white blood cells, platelets, or plasma, leading to issues such as anemia, clotting disorders, or immune system deficiencies. The increasing prevalence of blood disorders is rising due to the aging population, as aging leads to a decline in bone marrow function, making older adults more susceptible to conditions like anemia, thrombocytopenia, and clotting disorders. Blood platelets enhance blood disorder treatments by regulating blood clotting, making them essential for preventing excessive bleeding and supporting wound healing. For instance, in October 2025, according to the World Federation of Hemophilia (WFH) Annual Global Survey (AGS) In 2024, the data reveals a 6% rise in the global identification of individuals with hemophilia, a 6% rise in those identified with VWD, and a 9% rise in the detection of other inherited bleeding disorders. Therefore, the increasing prevalence of blood disorders is driving the growth of the blood platelets industry.

Key Players In The Global Blood Platelets Market

Major companies operating in the blood platelets market are Fresenius Kabi, Grifols S.A., CSL Behring, Octapharma AG, Terumo Corporation, Cerus Corporation, Macopharma, Biotest AG, Kedrion Biopharma, Bio Products Laboratory Ltd, LFB Group, Hemanext Inc, Cellphire Inc, American Red Cross, Sanquin, Canadian Blood Services, Australian Red Cross Lifeblood, New York Blood Center, Vitalant, HemaCare

Global Blood Platelets Market Trends and Insights

Major companies operating in the blood platelet market are focusing on developing innovative solutions, such as platelet pooling to extend shelf life, enhance availability, and support blood centers in meeting growing transfusion demands. Platelet pooling refers to the process of combining platelets from multiple whole blood donations to create a single platelet unit for transfusion, improving availability, efficiency, and resource utilization in blood supply management. For instance, in February 2023, Terumo Blood and Cell Technologies, a US-based medical technology company, launched the IMUGARD WB platelet pooling set after receiving U.S. Food and Drug Administration (FDA) clearance. The innovation extends the shelf life of whole blood-derived platelets from five to seven days, enhancing platelet availability for transfusion. It also provides an alternative source of platelet supply to address rising demand and donor shortages, helping blood centers improve inventory management and reduce waste.

What Are Latest Mergers And Acquisitions In The Blood Platelets Market?

In December 2023, Sysmex Corporation, a Japan-based healthcare and diagnostics company, acquired additional shares in Megakaryon Corporation for an undisclosed amount. With this acquisition, Sysmex aims to accelerate the commercialization of high-quality, high-quality induced pluripotent stem (iPS) cell-derived platelets by leveraging Megakaryon’s technology, strengthening group synergies, and advancing regenerative medicine through automation and quality control innovations. Megakaryon Corporation is a Japan-based biotechnology company specializing in the production of human induced pluripotent stem (iPS) cell-derived platelets for safer and sustainable blood transfusions.

Regional Outlook

North America was the largest region in the blood platelets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Blood Platelets Market?

The blood platelets market consists of sales of platelet apheresis kits, platelet storage systems, platelet-derived growth factors (PDGFs), platelet function analyzers and platelet transfusion services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Blood Platelets Market Report 2026?

The blood platelets market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the blood platelets industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.